The global sirolimus market size is expected to grow at a compound annual growth rate of 5.8% from 2024 to 2030. Sirolimus is a mTOR inhibitor drug used for immunosuppression in patients. The increasing number of organ transplantations is the major reason behind the growth of the sirolim... Read More »
January 2024The global aminophylline market size is expected to grow at a compound annual growth rate (CAGR) of 2.3% from 2024 to 2030. This growth can be attributed to the rising prevalence of respiratory disorders, a surging demand for cost-effective treatment options, and an increasing number of ... Read More »
January 2024The global barbiturate drugs market size was valued at USD 483 million in 2023 and is expected to grow at a compound annual growth rate (CAGR) of 3.12% from 2024 to 2030. Barbiturate drugs are a class of drugs that primarily act on the central nervous system. They were historically used ... Read More »
January 2024The global medical foods market size was valued at USD 23.5 billion in 2023 and is projected to grow at a compound annual growth rate (CAGR) of 5.1% 2024 to 2030. The market growth is driven by the rising prevalence of chronic diseases like Alzheimer's, ADHD, osteoporosis, osteoarthritis... Read More »
January 2024The global alopecia market was estimated at USD 8.77 billion in 2023 and is anticipated to grow at a compound annual growth rate (CAGR) of 9.1% from 2024 to 2030. One of the major driving factors for the market is the increasing awareness regarding alopecia treatment options, as people a... Read More »
January 2024The global lidocaine hydrochloride market size is expected to grow at a compound annual growth rate (CAGR) of 6.5% from 2024 to 2030. The growing number of surgical procedures and an increase in the number of dental, cosmetic, and plastic surgeries conducted globally are contributing to ... Read More »
January 2024The global alexipharmic drugs market was valued at USD 3.4 billion in 2022 and is projected to grow at a compound annual growth rate (CAGR) of 5.12% from 2023 to 2030. The primary factor contributing to the market's expansion is the global increase in mortality rates resulting from drug ... Read More »
January 2024The global anal fistula treatment market was valued at USD 756.23 million in 2022 and is expected to grow at a compound annual growth rate (CAGR) of 4.1% over the forecast period. The market growth is attributed to the increasing geriatric population, rising incidences of constipation, a... Read More »
January 2024The global carglumic acid market was valued at USD 137.2 million in 2023 and is expected to grow at a compound annual growth rate (CAGR) of 7.43% from 2024 to 2030. The growth of the carglumic acid market is attributed to several factors, including the increased prevalence of several can... Read More »
January 2024The global herpes simplex virus treatment market size was estimated at USD 2.47 billion in 2023 and is expected to grow at a compound annual growth rate (CAGR) of 8.1% from 2024 to 2030. The market growth can be attributed to the growing concerns over herpes simplex virus (HSV) infection... Read More »
January 2024The global benzodiazepine drugs market is expected to grow at a compound annual growth rate (CAGR) of 2.68% from 2024 to 2030. Major factors responsible for the market growth include the rising incidence of stress disorders and anxiety, the development of new effective medications for se... Read More »
January 2024The global opioid induced constipation market is anticipated to experience a compound annual growth rate (CAGR) of 4.6% from 2023 to 2030. The primary driver of this growth is the increasing number of geriatric patients who are prescribed opioid analgesics, such as morphine, hydromorphon... Read More »
January 2024The global tacrolimus market size is expected to grow at a compound annual growth rate (CAGR) of 5.3% from 2023 to 2030. The worldwide increase in the number of transplants and a surge in immunosuppressive research and development is anticipated to fuel the growth of the market. For inst... Read More »
January 2024The global fibrate drugs market size is expected to grow at a Compound Annual Growth Rate (CAGR) of 5.1% from 2023 to 2030. The global increase in the prevalence and incidence rate of cardiovascular disorders is anticipated to fuel the market for fibrate drugs. According to information p... Read More »
January 2024The global oxycodone drugs market is expected to grow at a compound annual growth rate (CAGR) of 5.8 % from 2023 to 2030. This growth is due to the increasing demand for effective pain management solution, and rising prevalence of chronic diseases like arthritis and cancer. Additionally,... Read More »
January 2024The global oral transmucosal drugs market is expected to grow at a compound annual growth rate (CAGR) of 7.8 % from 2023 to 2030. This growth is attributed to the escalating demand for efficient and rapid drug delivery systems, particularly for medications that necessitate swift absorpti... Read More »
January 2024The global lenalidomide market size is expected to grow at a compound annual growth rate (CAGR) of 5.2% from 2024 to 2030. The lenalidomide market is driven by its proven efficacy in treating multiple myelodysplastic syndromes & myeloma, versatile applications across various hematolo... Read More »
January 2024The global lipid regulators market size is expected to grow at a compound annual growth rate (CAGR) of 5.5% from 2024 to 2030. This growth is due to the increasing prevalence of lifestyle-related diseases such as hyperlipidemia and cardiovascular disorders, which necessitates the use of ... Read More »
January 2024The global liver metastases treatment market size was estimated at USD 1.63 billion in 2023 and is projected to grow at a compound annual growth rate (CAGR) of 7.3% from 2024 to 2030. This can be attributed to the rising incidence of the target disease. For instance, the American Cancer ... Read More »
January 2024The global antibiotic resistance market size was estimated at USD 8.72 billion in 2023 and is projected to grow at a compound annual growth rate (CAGR) of 5.27% from 2024 to 2030. The increasing burden of antibiotic-resistant infections is a major factor contributing to the market growth... Read More »
January 2024